Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05899361 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest

StatusCompleted
PhaseNot applicable
Started2023-08-30
View on ClinicalTrials.gov ↗

Amendment history

2026-10-01
notable
Trial completed
Final enrollment: 7 participants (planned 10)
Sponsor changed: Dana-Farber Cancer Institute → Brigham and Women's Hospitalrevised
WasDana-Farber Cancer Institute
NowBrigham and Women's Hospital
Study completion confirmed: August 2026 (last estimated December 2026)
2023-10-23
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Study sitesdetails revised at 1 of 1 site
2023-06-08
minor
Original filing
This research study is a pilot clinical trial, which hypothesizes that the combination of electromagnetic tracking in conjunction with laparoscope imaging and ultrasound probe imaging will aid in reducing the complexity of both laparoscopic lymphadenectomy and/or organ removal in patients with a confirmed diagnosis of cancer in urologic regions of interest (Bladder, Prostate, Testicular, Kidney, Urethral, and Penis), by resulting in better visualization and more accurate localization of certain areas in the diseased organ or the diseased lymph node, and allowing for improved surgical and patient outcomes, fewer complications and better clinician performance.
Trial Details
NCT Number NCT05899361
Lead Sponsor Brigham and Women's Hospital
Collaborators: Siemens Medical Solutions
Conditions Urologic Cancer, Urologic Neoplasms, Bladder Cancer, Prostate Cancer, Testicular Cancer, Kidney Cancer, Urethral Cancer, Penile Cancer
Enrollment 7 participants
Start Date 2023-08-30
Primary Completion 2025-08-26 (estimated)
Study Completion 2026-08-26 (estimated)
Updated on ClinicalTrials.gov 2026-09-30